Table 2.
Prevalence of anal canal human papillomavirus (HPV) in men having sex with women in São Paulo, Cuernavaca, and Tampa
| Variable | São Paulo n=265 |
Cuernavaca n=359 |
Tampa n=278 |
Combined Population n=902 |
Pa |
|---|---|---|---|---|---|
| Any HPV type | 29 (10.9) | 43 (12.0) | 36 (13.0) | 108 (12.0) | 0.77 |
| Any oncogenic typeb | 13 (4.9) | 26 (7.2) | 24 (8.6) | 63 (7.0) | 0.22 |
| Only oncogenic types | 7 (2.6) | 18 (5.0) | 20 (7.2) | 45 (5.0) | 0.05 |
| Any nononcogenic typec | 22 (8.3) | 25 (7.0) | 16 (5.8) | 63 (7.0) | 0.50 |
| Only nononcogenic types | 16 (6.0) | 17 (4.7) | 12 (4.3) | 45 (5.0) | 0.71 |
| Oncogenic and nononcogenic | 6 (2.3) | 8 (2.2) | 4 (1.4) | 18 (2.0) | 0.76 |
| Unclassified types only | 46 (17.4) | 65 (18.1) | 24 (8.6) | 135 (15.0) | 0.001 |
| Multiple types | 11 (4.2) | 9 (2.5) | 7 (2.5) | 27 (3.0) | 0.43 |
| Types 6 or 11 | 2 (0.8) | 5 (1.4) | 6 (2.2) | 13 (1.4) | 0.39 |
| Types 16 or 18 | 5 (1.9) | 5 (1.4) | 20 (7.2) | 30 (3.3) | < 0.001 |
| Types 6, 11, 16, or 18 | 6 (2.3) | 10 (2.8) | 24 (8.6) | 40 (4.4) | < 0.001 |
| Oncogenic typesd | |||||
| 16 | 4 (1.5) | 5 (1.4) | 20 (7.2) | 29 (3.2) | < 0.001 |
| 18 | 1 (0.4) | 0 (0.0) | 0 (0.0) | 1 (0.1) | 0.29 |
| 51 | 3 (1.1) | 4 (1.1) | 2 (0.7) | 9 (1.0) | 0.84 |
| 59 | 3 (1.1) | 6 (1.7) | 0 (0.0) | 9 (1.0) | 0.07 |
| 66 | 0 (0.0) | 4 (1.1) | 0 (0.0) | 4 (0.4) | 0.04 |
| Nononcogenic typese | |||||
| 6 | 2 (0.8) | 4 (1.1) | 6 (2.2) | 12 (1.3) | 0.38 |
| 11 | 0 (0.0) | 1 (0.3) | 0 (0.0) | 1 (0.1) | 1.00 |
| 40 | 0 (0.0) | 0 (0.0) | 3 (1.1) | 3 (0.3) | 0.05 |
| 53 | 5 (1.9) | 2 (0.6) | 1 (0.4) | 8 (0.9) | 0.19 |
| 61 | 1 (0.4) | 4 (1.1) | 0 (0.0) | 5 (0.6) | 0.16 |
| 62 | 8 (3.0) | 3 (0.8) | 1 (0.4) | 12 (1.3) | 0.02 |
| 84 | 2 (0.8) | 4 (1.1) | 2 (0.7) | 8 (0.9) | 0.91 |
| CP6108 | 8 (3.0) | 5 (1.4) | 0 (0.0) | 13 (1.4) | < 0.01 |
NOTE. Data are no. (%) of subjects.
a
Fisher exact test
b
Prevalence of at least 1 of 13 oncogenic types, regardless of the presence of any other HPV type.
c
Prevalence of at least 1 nononcogenic type, regardless of the presence of any other HPV type.
d
Oncogenic types 35, 39, 45, 52, 56, and 58 are not shown; each was detected in the anal canal, but the prevalence was < 1.0%. Types 31 and 33 were not detected.
e
Nononcogenic types 42, 55, 67, 68, 70, 71, 72, 81, 82, and 83 are not shown; each was detected in the anal canal, but the prevalence was < 1.0%. Types 26, 54, 64, 69, 73 and IS39 were not detected.